OREXO
Orexo develops improved specialty pharmaceuticals and treatments for new areas of use – at a lower cost, in a shorter period of time and at a lower risk – by combining known substances with patented proprietary technologies.
OREXO
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
1995-01-01
Address:
Uppsala, Uppsala Lan, Sweden
Country:
Sweden
Website Url:
http://www.orexo.com
Total Employee:
51+
Status:
Active
Contact:
46 1 87 80 88 00
Email Addresses:
[email protected]
Total Funding:
72.98 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon WordPress Google Universal Analytics Wordpress Plugins Nginx Organization Schema
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2009-02-23 | PharmaKodex | PharmaKodex acquired by Orexo | N/A |
| 2007-11-23 | Biolipox | Biolipox acquired by Orexo | N/A |
Investors List
Apex Venture Partners
Apex Venture Partners investment in Series B - Orexo
Crédit Lyonnais Private Equity
Crédit Lyonnais Private Equity investment in Series B - Orexo
HealthCap
HealthCap investment in Series B - Orexo
Sofinnova Investments
Sofinnova Investments investment in Series B - Orexo
Auriga Partners
Auriga Partners investment in Series B - Orexo
Key Employee Changes
| Date | New article |
|---|---|
| 2022-03-11 | Orexo appoints Fredrik Järrsten as new CFO |
| 2019-12-02 | Orexo Appoints Dennis Urbaniak as Executive Vice President Digital Health |
More informations about "Orexo"
Governance - Orexo
Orexo is a Swedish public company, with its registered office in Uppsala, Sweden. The company’s shares are listed on Nasdaq Stockholm´s main list under the symbol ORX and as an American …See details»
Corporate governance reports | Orexo
The corporate governance reports displayed below include information on the work of the nomination committee, the board of directors and the various committees, as well as …See details»
Orexo - Wikipedia
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialize…See details»
us.orexo.com | us.orexo.com
Who We Are. We are Orexo’s US operation, and we are integral to bringing innovative treatment solutions to patients in the United States. Our organization is focused on commercializing …See details»
Orexo - Crunchbase Company Profile & Funding
Orexo may be growing as it has recently submitted a New Drug Application (NDA) for a high-dose rescue medication for opioid addiction, which indicates an expansion of its product pipeline. …See details»
Orexo US, Inc. - us.orexo.com
Orexo US Inc. is a subsidiary of Orexo AB (publ.) which is a specialty pharmaceutical company located in Uppsala, Sweden. The US organization’s main mission is to commercialize the drug …See details»
Orexo AB (publ) (LON: 0H19) Company Profile & Overview - Stock …
1 day ago Orexo AB (publ), a specialty pharmaceutical company, develops and commercializes pharmaceuticals and digital therapies in the United States, European Union, and …See details»
US Leadership Team - Orexo
Rich Murphy joined Orexo US, Inc. in August 2013. He is the Senior Vice President, Market Access & Government Affairs. He has more than 30 years of industry experience at several …See details»
Hi and welcome | Orexo
When I joined Orexo the focus was solely on pharmaceutical research and development at our facilities in Uppsala, Sweden. Today, we’re pioneering new technologies and treatment routes …See details»
Orexo AB - Org Chart, Teams, Culture & Jobs - The Org
View Orexo AB's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
About Orexo – blog.orexo.com
The products are commercialized by Orexo in the US or via partners worldwide. Orexo is listed on the Nasdaq Stockholm Mid Cap (ORX) and is available as ADRs on OTCQX (ORXOY) in the …See details»
Orexo Company Profile - Office Locations, Competitors, Revenue …
Orexo has 5 employees across 3 locations and kr638.8 m in annual revenue in FY 2023. See insights on Orexo including office locations, competitors, revenue, financials, executives, …See details»
Orexo - Digital Therapeutics Alliance
Orexo develops improved pharmaceuticals and digital therapeutics addressing unmet needs mainly within the growing space of addiction. The products are commercialized by Orexo in …See details»
Who we are - Orexo
Orexo is a commercial-stage pharmaceutical company with an international footprint. We are passionate about improving people's lives by offering innovative treatment solutions. Today, …See details»
Orexo - Overview, News & Similar companies | ZoomInfo.com
Orexo shares new information on OX124, a high-dose naloxone rescue medication in development for opioid overdose Uppsala, Sweden – July 16, 2024 – Orexo AB (publ.), …See details»
Orexo Company Profile 2024: Stock Performance & Earnings
Orexo is headquartered in Uppsala, Sweden. What is the size of Orexo? Orexo has 113 total employees. What industry is Orexo in? Orexo’s primary industry is Pharmaceuticals. Is Orexo …See details»
Orexo CEO and Key Executive Team | Craft.co
Orexo's key executives include Staffan Lindstrand and 1 others. Staffan Lindstrand. Director. Nikolaj Sørensen. President and CEO. Source: orexo.com. Report incorrect company …See details»
Strategy for growth | Orexo
Orexo’s business strategy and its day-to-day operationalization are shaped by the company’s Ethical Code. The strategy supports Agenda 2030 and the Sustainable Development Goals …See details»
Orexo AB Revenue - Stock Analysis
1 day ago Orexo AB had revenue of 136.50M SEK in the quarter ending September 29, 2024, a decrease of -12.56%. This brings the company's revenue in the last twelve months to …See details»
Investors - Orexo
Orexo constantly strives to create long-term value for all its stakeholders. For both current and potential investors there are several factors that can contribute to the company's ability to …See details»